Shannon Soqui
Directeur/Bestuurslid bij ACKL SPAC
Actieve functies van Shannon Soqui
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ACKL SPAC | Directeur/Bestuurslid | 01-12-2020 | - |
Independent Dir/Board Member | 01-12-2020 | - | |
CMLM Holdings, Inc.
CMLM Holdings, Inc. Specialty StoresRetail Trade CMLM Holdings, Inc. provides hemp-formulated wellness and beauty products. The company is headquartered in Portland, OR. | President | - | - |
Bedrijfssecretaris | - | - | |
Hempyre Holdings Ltd.
Hempyre Holdings Ltd. Specialty StoresRetail Trade Hempyre Holdings Ltd. engages in the distribution of hemp-formulated consumer packaged goods for beauty, beverage, and wellness industries. The firm focuses on consumer hemp-formulated topical solutions to protect and rejuvenate the skin and body. Its product brands include QIND, Bio-Synergy, Muhu, QINDNESS, ActiVeman, Active Woman, Super7, Bottomley Distillers, Green Origin, Paways, and Wevapers. The company was founded on February 13, 2020 and is headquartered in London, the United Kingdom. | Directeur/Bestuurslid | - | - |
Algemeen Directeur | - | - | |
Next Frontier Brands
Next Frontier Brands Food DistributorsDistribution Services Next Frontier Brands engages in the provision of consumer goods. It offers beverage and hemp-based wellness brands. The company is headquartered in Boulder, CO. | Voorzitter | - | - |
Oprichter | - | - | |
Directeur/Bestuurslid | 01-04-2020 | 20-07-2021 | |
Algemeen Directeur | 01-04-2020 | 20-07-2021 | |
Next Frontier Pharmaceuticals, Inc.
Next Frontier Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Next Frontier Pharmaceuticals, Inc. is a drug developer and provider of cannabinoid and psychedelic APIs. The private company is based in Carrollton, TX. Its wholly owned subsidiary, Benuvia Manufacturing, Inc., owns the FDA-approved cannabinoid drug Syndros® and the largest captive synthetic cannabinoid manufacturing facility. The company's 83,000 square foot manufacturing facility is permitted by the U.S. DEA to manufacture and export Schedule I to III controlled substances and is FDA registered. Next Frontier Pharmaceuticals is pursuing a 505(b)(2) approval pathway with the FDA for six investigational new drugs (INDs). The company also has a robust portfolio of patents and patents pending on organic and synthetic cannabinoids and provides life cycle management services for drug development companies focused on cannabinoids and psychedelics. | Voorzitter | - | - |
Loopbaan van Shannon Soqui
Eerdere bekende functies van Shannon Soqui
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Ackrell Capital LLC
Ackrell Capital LLC Investment ManagersFinance Ackrell Capital LLC operates as an independent investment bank that focuses on providing financial advisory services. It offers M&A advisory, private placement and corporate development services. The company was founded by Michael Kevin Ackrell and William A. Lamkin in 2003 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | 01-01-2015 | 01-01-2017 |
Opleiding van Shannon Soqui
University of California | Undergraduate Degree |
The Santa Clara University School of Law | Graduate Degree |
Statistieken
Internationaal
Verenigde Staten | 8 |
Verenigd Koninkrijk | 2 |
Operationeel
Director/Board Member | 3 |
Chief Executive Officer | 2 |
Chairman | 2 |
Sectoraal
Retail Trade | 3 |
Finance | 3 |
Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 6 |
---|---|
CMLM Holdings, Inc.
CMLM Holdings, Inc. Specialty StoresRetail Trade CMLM Holdings, Inc. provides hemp-formulated wellness and beauty products. The company is headquartered in Portland, OR. | Retail Trade |
Hempyre Holdings Ltd.
Hempyre Holdings Ltd. Specialty StoresRetail Trade Hempyre Holdings Ltd. engages in the distribution of hemp-formulated consumer packaged goods for beauty, beverage, and wellness industries. The firm focuses on consumer hemp-formulated topical solutions to protect and rejuvenate the skin and body. Its product brands include QIND, Bio-Synergy, Muhu, QINDNESS, ActiVeman, Active Woman, Super7, Bottomley Distillers, Green Origin, Paways, and Wevapers. The company was founded on February 13, 2020 and is headquartered in London, the United Kingdom. | Retail Trade |
Next Frontier Brands
Next Frontier Brands Food DistributorsDistribution Services Next Frontier Brands engages in the provision of consumer goods. It offers beverage and hemp-based wellness brands. The company is headquartered in Boulder, CO. | Distribution Services |
Ackrell SPAC Partners I Co.
Ackrell SPAC Partners I Co. Financial ConglomeratesFinance Ackrell SPAC Partners I Co. is a blank check company. It plans to identify and to complete initial business combination in alcoholic and non-alcoholic beverage and wellness sectors of the fast-moving consumer goods market. The company was founded on September 11, 2018 and is headquartered in Claymont, DE. | Finance |
Ackrell Capital LLC
Ackrell Capital LLC Investment ManagersFinance Ackrell Capital LLC operates as an independent investment bank that focuses on providing financial advisory services. It offers M&A advisory, private placement and corporate development services. The company was founded by Michael Kevin Ackrell and William A. Lamkin in 2003 and is headquartered in San Francisco, CA. | Finance |
Next Frontier Pharmaceuticals, Inc.
Next Frontier Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Next Frontier Pharmaceuticals, Inc. is a drug developer and provider of cannabinoid and psychedelic APIs. The private company is based in Carrollton, TX. Its wholly owned subsidiary, Benuvia Manufacturing, Inc., owns the FDA-approved cannabinoid drug Syndros® and the largest captive synthetic cannabinoid manufacturing facility. The company's 83,000 square foot manufacturing facility is permitted by the U.S. DEA to manufacture and export Schedule I to III controlled substances and is FDA registered. Next Frontier Pharmaceuticals is pursuing a 505(b)(2) approval pathway with the FDA for six investigational new drugs (INDs). The company also has a robust portfolio of patents and patents pending on organic and synthetic cannabinoids and provides life cycle management services for drug development companies focused on cannabinoids and psychedelics. | Health Technology |
- Beurs
- Insiders
- Shannon Soqui
- Ervaring